Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
Riveiro-Barciela M, Bes M, Rodríguez-Frías F, Tabernero D, Ruiz A, Casillas R, Vidal-González J, Homs M, Nieto L, Sauleda S, Esteban R, Buti M. Riveiro-Barciela M, et al. Clin Microbiol Infect. 2017 Nov;23(11):860-867. doi: 10.1016/j.cmi.2017.03.003. Epub 2017 Mar 11. Clin Microbiol Infect. 2017. PMID: 28288829 Free article.
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU.
Riveiro-Barciela M, Carballal S, Díaz-González Á, Mañosa M, Gallgo-Plazas J, Cubiella J, Jiménez-Fonseca P, Varela M, Menchén L, Sangro B, Fernández-Montes A, Mesonero F, Rodríguez-Gandía MÁ, Rivera F, Londoño MC. Riveiro-Barciela M, et al. Rev Esp Enferm Dig. 2024 Feb;116(2):83-113. doi: 10.17235/reed.2024.10250/2024. Rev Esp Enferm Dig. 2024. PMID: 38226597 Free article.
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
Kocheise L, Piseddu I, Vonderlin J, Tjwa ET, Buescher G, Meunier L, Goeggelmann P, Fianchi F, Dumortier J, Riveiro Barciela M, Gevers TJG, Terziroli Beretta-Piccoli B, Londoño MC, Frankova S, Roesner T, Joerg V, Schmidt C, Glaser F, Sutter JP, Fründt TW, Lohse AW, Huber S, von Felden J, Sebode M, Schulze K. Kocheise L, et al. Front Immunol. 2024 Jan 10;14:1326078. doi: 10.3389/fimmu.2023.1326078. eCollection 2023. Front Immunol. 2024. PMID: 38268921 Free PMC article.
[Hepatitis E: scale of the problem in Spain].
Riveiro-Barciela M, Rodríguez-Frías F, Buti M. Riveiro-Barciela M, et al. Gastroenterol Hepatol. 2012 Dec;35(10):719-24. doi: 10.1016/j.gastrohep.2012.03.003. Epub 2012 May 17. Gastroenterol Hepatol. 2012. PMID: 22608490 Review. Spanish.
Hepatitis E virus: new faces of an old infection.
Riveiro-Barciela M, Rodríguez-Frías F, Buti M. Riveiro-Barciela M, et al. Ann Hepatol. 2013 Nov-Dec;12(6):861-70. Ann Hepatol. 2013. PMID: 24114815 Free article. Review.
[Importance of hepatitis B virus screening in hematological patients].
Riveiro-Barciela M, Artaza G, Abrisqueta P, Bosch F, Buti M. Riveiro-Barciela M, et al. Gastroenterol Hepatol. 2015 Nov;38(9):563-4. doi: 10.1016/j.gastrohep.2015.03.004. Epub 2015 Apr 14. Gastroenterol Hepatol. 2015. PMID: 25888287 Spanish. No abstract available.
Therapy for hepatitis C genotype 3: moving forward.
Buti M, Llaneras J, Riveiro-Barciela M, Esteban R. Buti M, et al. J Viral Hepat. 2015 Sep;22(9):683-90. doi: 10.1111/jvh.12419. Epub 2015 May 13. J Viral Hepat. 2015. PMID: 25967352 Review.
141 results